{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:54:32Z","timestamp":1788821672899,"version":"build-2803163510"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.humpath.2025.106012","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:21:39Z","timestamp":1765498899000},"page":"106012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Three practice updates in non-Hodgkin lymphoma for 2026"],"prefix":"10.1016","volume":"169","author":[{"given":"Rebecca L.","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Ondrejka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-8085","authenticated-orcid":false,"given":"James R.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2025.106012_bib1","series-title":"Cancer facts & figures 2025","year":"2025"},{"key":"10.1016\/j.humpath.2025.106012_bib2","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/ijc.34163","article-title":"Global patterns of Non-Hodgkin lymphoma in 2020","volume":"151","author":"Mafra","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2025.106012_bib3","series-title":"WHO classification of haematolymphoid tumours","year":"2024"},{"key":"10.1016\/j.humpath.2025.106012_bib4","series-title":"The international consensus classification of myeloid and lymphoid neoplasms","author":"Arber","year":"2025"},{"key":"10.1016\/j.humpath.2025.106012_bib5","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood.2022015854","article-title":"Genomic profiling for clinical decision making in lymphoid neoplasms","volume":"140","author":"de Leval","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/PAP.0000000000000481","article-title":"Diagnosis and classification of follicular lymphoma and related entities","volume":"32","author":"Laurent","year":"2025","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00428-022-03432-2","article-title":"Follicular lymphoma and marginal zone lymphoma: how many diseases?","volume":"482","author":"Laurent","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2025.106012_bib8","series-title":"Haematolymphoid tumours","author":"Board","year":"2024"},{"key":"10.1016\/j.humpath.2025.106012_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/PAS.0000000000001015","article-title":"Comparison of myocyte enhancer factor 2B versus other germinal center-associated antigens in the differential diagnosis of B-Cell non-hodgkin lymphomas","volume":"42","author":"Moore","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1309\/AJCP7Z2BIBUNQPLZ","article-title":"The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow","volume":"135","author":"Younes","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.seminoncol.2018.07.005","article-title":"New concepts in follicular lymphoma biology: from BCL2 to epigenetic regulators and non-coding RNAs","volume":"45","author":"Devan","year":"2018","journal-title":"Semin Oncol"},{"key":"10.1016\/j.humpath.2025.106012_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2025.106012_bib13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood.V68.4.837.837","article-title":"What should be the morphologic criteria for the subdivision of follicular lymphomas?","volume":"68","author":"Nathwani","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.1985.3.1.25","article-title":"Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the repository center and pathology panel for lymphoma clinical studies","volume":"3","author":"Metter","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.106012_bib15","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","year":"2017"},{"key":"10.1016\/j.humpath.2025.106012_bib16","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/PAS.0000000000001726","article-title":"High-grade follicular lymphomas exhibit clinicopathologic, cytogenetic, and molecular diversity extending beyond grades 3A and 3B","volume":"45","author":"Laurent","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/PAS.0b013e318224e661","article-title":"Primary follicular lymphoma of the gastrointestinal tract","volume":"35","author":"Misdraji","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/00000478-200005000-00007","article-title":"Increased incidence of follicular lymphoma in the duodenum","volume":"24","author":"Yoshino","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib19","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1200\/JCO.2010.32.9193","article-title":"Primary follicular lymphoma of the duodenum is a distinct mucosal\/submucosal variant of follicular lymphoma: a retrospective study of 63 cases","volume":"29","author":"Schmatz","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.106012_bib20","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.106012_bib21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/modpathol.3880398","article-title":"Cutaneous follicle center lymphoma: a clinicopathologic study of 19 cases","volume":"14","author":"Aguilera","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humpath.2020.09.014","article-title":"The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma","volume":"106","author":"Barasch","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1309\/AJCP4SUBR4NPSPTN","article-title":"Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions","volume":"143","author":"Pham-Ledard","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/bloodadvances.2020002469","article-title":"Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features","volume":"5","author":"Zhou","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2025.106012_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/PAS.0b013e31802ee4ab","article-title":"Primary follicular lymphoma of the testis and epididymis in adults","volume":"31","author":"Bacon","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib26","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/bloodadvances.2024014002","article-title":"Genomic landscape of testicular follicular lymphoma is characterized by frequent 1p36\/TNFRSF14 alterations","volume":"9","author":"Zhang","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2025.106012_bib27","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/jcp.55.9.684","article-title":"Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics","volume":"55","author":"Pileri","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00043426-200402000-00007","article-title":"Primary follicular lymphoma of the testis: excellent outcome following surgical resection without adjuvant chemotherapy","volume":"26","author":"Heller","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.humpath.2025.106012_bib29","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1626::AID-CNCR27>3.0.CO;2-0","article-title":"Primary follicular lymphoma of the testis in childhood","volume":"85","author":"Finn","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2025.106012_bib30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1182\/blood-2015-12-682591","article-title":"Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations","volume":"128","author":"Louissaint","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib31","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood-2012-05-429514","article-title":"Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement","volume":"120","author":"Louissaint","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PAS.0b013e31826b9b57","article-title":"Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma","volume":"37","author":"Liu","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib33","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1182\/bloodadvances.2022007322","article-title":"A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile","volume":"6","author":"Salmeron-Villalobos","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2025.106012_bib34","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood."},{"key":"10.1016\/j.humpath.2025.106012_bib35","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A distinctive subtype of t(14;18)-negative nodal follicular Non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/modpathol.2016.51","article-title":"Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36\/TNFRSF14 abnormalities, and STAT6 mutations","volume":"29","author":"Siddiqi","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib37","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1182\/bloodadvances.2022009456","article-title":"The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas","volume":"7","author":"Salaverria","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2025.106012_bib38","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","article-title":"Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease","volume":"4","author":"Nann","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2025.106012_bib39","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib40","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","volume":"114","author":"Savage","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib41","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1200\/JCO.19.00743","article-title":"Prognostic significance of MYC rearrangement and translocation partner in diffuse large B-Cell lymphoma: a study by the lunenburg lymphoma biomarker consortium","volume":"37","author":"Rosenwald","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.106012_bib42","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","article-title":"MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma","volume":"121","author":"Horn","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib43","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/leu.2008.230","article-title":"Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German high-grade Non-Hodgkin's lymphoma study group (DSHNHL)","volume":"22","author":"Klapper","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2025.106012_bib44","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3324\/haematol.2018.190157","article-title":"Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements is not associated with MYC\/IG gene rearrangements","volume":"103","author":"McPhail","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2025.106012_bib45","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood-2015-05-647602","article-title":"MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA\/LYSA study","volume":"126","author":"Copie-Bergman","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib46","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib47","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1182\/bloodadvances.2023009731","article-title":"High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study","volume":"7","author":"Zayac","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2025.106012_bib48","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/bjh.12982","article-title":"Double hit lymphoma: the MD Anderson cancer center clinical experience","volume":"166","author":"Oki","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2025.106012_bib49","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3324\/haematol.2021.279631","article-title":"Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and\/or BCL6 rearrangements characterized by whole-exome sequencing","volume":"107","author":"K\u00fcnstner","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2025.106012_bib50","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41375-019-0691-6","article-title":"Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC\/BCL2 double-hit","volume":"34","author":"Cucco","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2025.106012_bib51","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.3324\/haematol.2018.198572","article-title":"Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements","volume":"104","author":"Evrard","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2025.106012_bib52","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/his.12178","article-title":"MYC status determination in aggressive B-cell lymphoma: the impact of FISH probe selection","volume":"63","author":"Mu\u00f1oz-M\u00e1rmol","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.106012_bib53","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.leu.2404529","article-title":"Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas","volume":"21","author":"Bertrand","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2025.106012_bib54","first-page":"2493","article-title":"Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population","volume":"141","author":"Alduaij","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib55","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.3324\/haematol.2018.207290","article-title":"False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms","volume":"104","author":"King","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2025.106012_bib56","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/PAS.0000000000000818","article-title":"Further exploration of the complexities of large B-Cell lymphomas with MYC abnormalities and the importance of a blastoid morphology","volume":"41","author":"Moore","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib57","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1182\/blood-2017-12-820605","article-title":"High-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology","volume":"131","author":"Scott","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib58","article-title":"Characterization of the genetic landscape of high-grade B-cell lymphoma, NOS \u2013 an LLMPP project","volume":"39","author":"Collinge","year":"2021","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.humpath.2025.106012_bib59","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41375-022-01778-9","article-title":"High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL\/HGBL-DH than DLBCL","volume":"37","author":"Li","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2025.106012_bib60","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.18632\/oncotarget.6262","article-title":"Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma","volume":"7","author":"Ye","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2025.106012_bib61","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/his.12884","article-title":"MYC\/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis","volume":"68","author":"Li","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.106012_bib62","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAS.0b013e31826cebad","article-title":"Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas","volume":"37","author":"Pillai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100710","article-title":"Diffuse large B-Cell Lymphoma\/high-grade B-Cell lymphoma with MYC and BCL6 rearrangements: a study of 60 cases","volume":"38","author":"Kim","year":"2025","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib64","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1200\/JCO.18.01583","article-title":"Double-hit gene expression signature defines a distinct subgroup of germinal center B-Cell-Like diffuse large B-Cell lymphoma","volume":"37","author":"Ennishi","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.106012_bib65","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1182\/bloodadvances.2025016651","article-title":"High-grade B-cell lymphoma, not otherwise specified: an LLMPP study","volume":"9","author":"Collinge","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2025.106012_bib66","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ajh.27513","article-title":"High-grade B-cell lymphoma not otherwise specified, with diffuse large B-cell lymphoma gene expression signatures: genomic analysis and potential therapeutics","volume":"100","author":"Lone","year":"2025","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2025.106012_bib67","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1182\/blood.2019002600","article-title":"The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH","volume":"134","author":"Hilton","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib68","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.18.01314","article-title":"Molecular high-grade B-Cell lymphoma: defining a poor-risk group that requires different approaches to therapy","volume":"37","author":"Sha","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.106012_bib69","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.1182\/bloodadvances.2023010402","article-title":"Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study","volume":"7","author":"Urata","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2025.106012_bib70","series-title":"Types of T-cell lymphomas","year":"2025"},{"key":"10.1016\/j.humpath.2025.106012_bib71","series-title":"Peripheral T-cell lymphoma","year":"2025"},{"key":"10.1016\/j.humpath.2025.106012_bib72","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib73","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","article-title":"Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation","volume":"67","author":"Piccaluga","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2025.106012_bib74","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","author":"Dobay","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2025.106012_bib75","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/PAS.0b013e31817f123e","article-title":"Peripheral T-cell lymphoma with follicular T-cell markers","volume":"32","author":"Rodr\u00edguez-Pinilla","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib76","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma","volume":"148","author":"de Leval","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2025.106012_bib77","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.3324\/haematol.2015.126300","article-title":"Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets","volume":"100","author":"de Leval","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2025.106012_bib78","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","article-title":"Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas","volume":"33","author":"Huang","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib79","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1309\/AJCPBPNV86VZENGV","article-title":"Clinicopathologic analysis of peripheral T-cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-cell lymphoma: Bcl-6 expression might affect progression between these disorders","volume":"137","author":"Miyoshi","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib80","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00000478-200103000-00015","article-title":"Peripheral T-cell lymphoma with follicular involvement and a CD4+\/bcl-6+ phenotype","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib81","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.3324\/haematol.2023.282716","article-title":"Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions","volume":"108","author":"Bisig","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2025.106012_bib82","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2559.2011.03981.x","article-title":"Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive","volume":"59","author":"Agostinelli","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.106012_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ajcp\/aqab090","article-title":"How I diagnose angioimmunoblastic T-Cell lymphoma","volume":"156","author":"Xie","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib84","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/PAS.0000000000001315","article-title":"Application of a 5 marker Panel to the routine diagnosis of peripheral T-Cell lymphoma with T-Follicular helper phenotype","volume":"43","author":"Basha","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib85","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e3182785610","article-title":"Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin\/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist","volume":"37","author":"Nicolae","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib86","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.humpath.2020.05.006","article-title":"A suggested immunohistochemical algorithm for the classification of T-cell lymphomas involving lymph nodes","volume":"102","author":"Vega","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib87","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib88","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","article-title":"Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project","volume":"31","author":"Federico","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.106012_bib89","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00000478-199506000-00008","article-title":"Dilantin-associated lymphadenopathy. Spectrum of histopathologic patterns","volume":"19","author":"Abbondazo","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib90","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/PAS.0b013e3181cc7e79","article-title":"PD-1 expression in T-cell lymphomas and reactive lymphoid entities: potential overlap in staining patterns between lymphoma and viral lymphadenitis","volume":"34","author":"Krishnan","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib91","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.leu.2404467","article-title":"Improved reliability of lymphoma diagnostics via PCR-based clonality testing:\u2014Report of the BIOMED-2 concerted action BHM4-CT98-3936","volume":"21","author":"Van Krieken","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2025.106012_bib92","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronn\u00e9","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2025.106012_bib93","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/bloodadvances.2020001636","article-title":"Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms","volume":"4","author":"Lewis","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2025.106012_bib94","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41379-018-0037-3","article-title":"Adult T-cell leukemia\/lymphoma can be indistinguishable from other more common T-cell lymphomas. The university of Miami experience with a large cohort of cases","volume":"31","author":"Khanlari","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib95","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/DAD.0000000000000258","article-title":"Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas","volume":"37","author":"Bosisio","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2025.106012_bib96","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/PAS.0000000000000956","article-title":"Expression of TFH markers and detection of RHOA p.G17V and IDH2 p.R172K\/S mutations in cutaneous localizations of angioimmunoblastic T-Cell lymphomas","volume":"41","author":"Leclaire Alirkilicarslan","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib97","series-title":"The international consensus classification of Myeloid and lymphoid neoplasms","year":"2025"},{"key":"10.1016\/j.humpath.2025.106012_bib98","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00428-022-03412-6","article-title":"Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas","volume":"482","author":"Feldman","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2025.106012_bib99","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/ajcp\/aqab012","article-title":"How I diagnose Anaplastic large cell lymphoma","volume":"155","author":"Amador","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib100","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","article-title":"ALK-positive lymphoma: a single disease with a broad spectrum of morphology","volume":"91","author":"Benharroch","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib101","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib102","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","article-title":"Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"40","author":"King","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib103","first-page":"2915","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"10.1016\/j.humpath.2025.106012_bib104","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2019000779","article-title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry","volume":"134","author":"Amador","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.106012_bib105","series-title":"WHO classification of hematolymphoid tumours","year":"2024"},{"key":"10.1016\/j.humpath.2025.106012_bib106","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s41379-022-01022-w","article-title":"Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations","volume":"35","author":"Nicolae","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.106012_bib107","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2025.106012_bib108","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PAS.0000000000000323","article-title":"T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases","volume":"39","author":"Kato","year":"2015","journal-title":"Am J Surg Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725002990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725002990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:37:25Z","timestamp":1772725045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817725002990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":108,"alternative-id":["S0046817725002990"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.106012","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three practice updates in non-Hodgkin lymphoma for 2026","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.106012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106012"}}